Armata Pharmaceuticals, Inc. ARMP Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001558370-25-007765
cik 921114
name ARMATA PHARMACEUTICALS, INC.
sic 2836
countryba US
stprba CA
cityba LOS ANGELES
zipba 90066
bas1 5005 MCCONNELL AVE
bas2
baph 310-665-2928
countryma US
stprma CA
cityma LOS ANGELES
zipma 90066
mas1 5005 MCCONNELL AVE
mas2
countryinc US
stprinc WA
ein 911549568
former AMPLIPHI BIOSCIENCES CORP
changed 20130222
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250514
accepted 2025-05-14 16:23:00.0
prevrpt 0
detail 1
instance armp-20250331x10q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001558370-25-007765 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 781000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Accounts Payable And Accrued Liabilities Current 2055000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities -1488000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Increase Decrease In Operating Lease Liability -250000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Intangible Assets Net Excluding Goodwill 10256000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Liabilities Fair Value Adjustment 5203000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Net Cash Provided By Used In Investing Activities -250000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Net Income Loss -6531000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Net Income Loss -6531000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20240331 Operating Expenses 11194000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Operating Income Loss -10228000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Operating Lease Liability Current 4431000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Other Assets Current 744000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Other Nonoperating Expense 3602000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Other Nonoperating Income 52000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Payments Related To Tax Withholding For Share Based Compensation 14000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Payments To Acquire Property Plant And Equipment 250000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Prepaid Expense And Other Assets Current 1240000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Proceeds From Issuance Of Secured Debt 34889000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Profit Loss -6531000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Research And Development Expense Excluding Acquired In Process Cost 5429000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Restricted Stock Shares Issued Net Of Shares For Tax Withholdings 10412.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20241231 Retained Earnings Accumulated Deficit -327735000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Stockholders Equity 279354000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20241231 Additional Paid In Capital 279354000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 534000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 534000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 781000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20250331 Assets 87250000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 43340000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 17078000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Convertible Debt Current 27694000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Earnings Per Share Diluted -0.6900 USD 1 us-gaap/2024
0001558370-25-007765 20240331 General And Administrative Expense 3178000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 General And Administrative Expense 3178000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20241231 Liabilities 134456000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Long Term Debt Current Maturities Other Than Convertible Debt Current 38954000.0000 USD 0 0001558370-25-007765
0001558370-25-007765 20250331 Net Cash Provided By Used In Financing Activities 9986000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Operating Income Loss -10228000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Other Nonoperating Income Expense 1660000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Payments To Acquire Property Plant And Equipment 99000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Research And Development Expense Excluding Acquired In Process Cost 5429000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Restricted Stock Returned Shares Issued Net Of Tax Withholdings 4222.0000 shares 1 0001558370-25-007765 Equity Components= Common Stock;
0001558370-25-007765 20250331 Restricted Stock Value Shares Issued Net Of Tax Withholdings -14000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Restricted Stock Value Shares Issued Net Of Tax Withholdings -14000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20240331 Revenue Not From Contract With Customer 966000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Revenue Not From Contract With Customer 966000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20241231 Secured Long Term Debt 22539000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Stockholders Equity -56510000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001558370-25-007765 20241231 Common Stock Shares Authorized 217000000.0000 shares 0 us-gaap/2024
0001558370-25-007765 20241231 Deferred Income Tax Liabilities Net 3077000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Earnings Per Share Basic -0.1800 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Increase Decrease Fair Value Of Liabilities 13025000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20240331 Increase Decrease In Deferred Compensation 180000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -539000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Net Cash Provided By Used In Financing Activities 34931000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Net Income Loss -25021000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Operating Income Loss -8191000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Other Assets Noncurrent 975000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Other Noncash Expense 3596000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Other Nonoperating Income Expense -14793000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Proceeds From Exercise Of Warrants And Stock Options 42000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20250331 Shares Outstanding 36193479.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20241231 Stockholders Equity -48019000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Weighted Average Number Of Diluted Shares Outstanding 36124980.0000 shares 1 us-gaap/2024
0001558370-25-007765 20241231 Assets 86437000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Cash And Cash Equivalents At Carrying Value 9291000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Cash And Cash Equivalents At Carrying Value 11688000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Depreciation Depletion And Amortization 377000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 General And Administrative Expense 3253000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Goodwill 3490000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Increase Decrease In Operating Lease Right Of Use Asset -464000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20241231 Liabilities Current 48249000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Liabilities Fair Value Adjustment -13025000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Net Cash Provided By Used In Investing Activities -99000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Net Income Loss -6531000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20240331 Noncash Interest Income 26000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20240331 Other Noncash Expense 1815000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Other Nonoperating Income 59000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Property Plant And Equipment Net 12883000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Retained Earnings Accumulated Deficit -334266000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Stockholders Equity 361000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20250331 Stockholders Equity 362000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20240331 Stock Issued During Period Shares Stock Options Exercised 13407.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20250331 Additional Paid In Capital 280121000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Assets Current 13166000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Common Stock Shares Authorized 217000000.0000 shares 0 us-gaap/2024
0001558370-25-007765 20250331 Common Stock Shares Issued 36193479.0000 shares 0 us-gaap/2024
0001558370-25-007765 20241231 Common Stock Shares Outstanding 36183067.0000 shares 0 us-gaap/2024
0001558370-25-007765 20250331 Deferred Income Tax Liabilities Net 3077000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Depreciation Depletion And Amortization 317000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 General And Administrative Expense 3253000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Liabilities And Stockholders Equity 86437000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Long Term Debt Current Maturities Other Than Convertible Debt Current 75089000.0000 USD 0 0001558370-25-007765
0001558370-25-007765 20240331 Net Cash Provided By Used In Operating Activities -10584000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Operating Lease Liability Current 4459000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Other Assets Noncurrent 975000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Other Liabilities Current 529000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Revenue Not From Contract With Customer 491000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Revenue Not From Contract With Customer 491000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20241231 Shares Outstanding 36183067.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20231231 Stockholders Equity -32065000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20231231 Stockholders Equity 276393000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20231231 Stockholders Equity 361000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 19243000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Other Liabilities Current 337000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Profit Loss -25021000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Assets Current 11308000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Cash And Cash Equivalents At Carrying Value 37860000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Common Stock Shares Issued 36183067.0000 shares 0 us-gaap/2024
0001558370-25-007765 20241231 Common Stock Value 362000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Contribution Of Property 9000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction 26000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Deferred Compensation Liability Current 1347000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Earnings Per Share Basic -0.6900 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities -553000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Increase Decrease In Operating Lease Liability -2181000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Increase Decrease In Operating Lease Right Of Use Asset -597000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -1797000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Liabilities Current 110540000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Net Income Loss -25021000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Operating Expenses 11194000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Operating Expenses 8682000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Operating Income Loss -8191000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Other Assets Current 238000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Share Based Compensation 781000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20231231 Shares Outstanding 36122932.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20231231 Stockholders Equity -308819000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20250331 Stockholders Equity -53783000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Stock Issued During Period Value Stock Options Exercised 42000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Stock Issued During Period Value Stock Options Exercised 42000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20250331 Net Cash Provided By Used In Operating Activities -7580000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Liabilities And Stockholders Equity 87250000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Accounts Payable And Accrued Liabilities Current 1614000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 24097000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 2307000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001558370-25-007765 20250331 Common Stock Shares Outstanding 36193479.0000 shares 0 us-gaap/2024
0001558370-25-007765 20250331 Earnings Per Share Diluted -0.2000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Goodwill 3490000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Intangible Assets Net Excluding Goodwill 10256000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Operating Lease Liability Noncurrent 27694000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Operating Lease Liability Noncurrent 27416000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Other Nonoperating Expense 1820000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Other Nonoperating Income Expense 1660000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20241231 Prepaid Expense And Other Assets Current 1273000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Property Plant And Equipment Net 13241000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Research And Development Expense Excluding Acquired In Process Cost 8016000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Research And Development Expense Excluding Acquired In Process Cost 8016000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Restricted Cash Noncurrent 5390000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Stockholders Equity -333840000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20241231 Stockholders Equity 362000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20241231 Stockholders Equity -327735000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20250331 Stockholders Equity -334266000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20250331 Weighted Average Number Of Shares Outstanding Basic 36184802.0000 shares 1 us-gaap/2024
0001558370-25-007765 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14771000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Common Stock Value 362000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Contribution Of Property 425000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20241231 Convertible Debt Noncurrent 32897000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Deferred Compensation Liability Current 2280000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Increase Decrease Fair Value Of Liabilities 31400000.0000 USD 4 0001558370-25-007765 Counterparty Name= Innoviva Strategic Opportunities Llc; Debt Instrument= Secured Term Loan;
0001558370-25-007765 20250331 Increase Decrease Fair Value Of Liabilities -5203000.0000 USD 1 0001558370-25-007765
0001558370-25-007765 20250331 Increase Decrease In Deferred Compensation -933000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Liabilities 141033000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Net Income Loss -25021000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001558370-25-007765 20250331 Operating Expenses 8682000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20241231 Operating Lease Right Of Use Asset 41687000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20250331 Operating Lease Right Of Use Asset 41090000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Other Nonoperating Income Expense -14793000.0000 USD 1 us-gaap/2024 Business Segments= Single Reportable Segment;
0001558370-25-007765 20250331 Proceeds From Issuance Of Secured Debt 10000000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20250331 Property Plant And Equipment Net 12900000.0000 USD 0 us-gaap/2024 Business Segments= Single Reportable Segment; Geographical= U S;
0001558370-25-007765 20240331 Restricted Cash Noncurrent 5480000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20241231 Restricted Cash Noncurrent 5480000.0000 USD 0 us-gaap/2024
0001558370-25-007765 20240331 Share Based Compensation 534000.0000 USD 1 us-gaap/2024
0001558370-25-007765 20240331 Shares Outstanding 36132117.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001558370-25-007765 20240331 Stockholders Equity 276969000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20250331 Stockholders Equity 280121000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001558370-25-007765 20250331 Weighted Average Number Of Diluted Shares Outstanding 59478662.0000 shares 1 us-gaap/2024
0001558370-25-007765 20240331 Weighted Average Number Of Shares Outstanding Basic 36124980.0000 shares 1 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Other Nonoperating Income us-gaap/2024 0 0 monetary D C Other Nonoperating Income Amount of income related to nonoperating activities, classified as other.
Restricted Stock Returned Shares Issued Net Of Tax Withholdings 0001558370-25-007765 1 0 shares D Restricted Stock Returned Shares Issued Net Of Tax Withholdings Restricted stock returned shares issued net of tax withholdings.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Secured Long Term Debt us-gaap/2024 0 0 monetary I C Secured Long-Term Debt, Noncurrent Carrying amount of collateralized debt obligations with maturities initially due after one year or beyond the operating cycle, if longer, excluding the current portion. Obligations include, but not limited to, mortgage loans, chattel loans, and other borrowings secured by assets.
Noncash Interest Income 0001558370-25-007765 1 0 monetary D C Noncash Interest Income Amount of interest income included in net income that result in no cash inflow
Increase Decrease In Deferred Compensation us-gaap/2024 0 0 monetary D D Increase (Decrease) in Deferred Compensation The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.
Accounts Payable And Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
Deferred Compensation Liability Current us-gaap/2024 0 0 monetary I C Deferred Compensation Liability, Current Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Other Noncash Expense us-gaap/2024 0 0 monetary D D Other Noncash Expense Amount of expense or loss included in net income that result in no cash flow, classified as other.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Convertible Debt Noncurrent us-gaap/2024 0 0 monetary I C Convertible Debt, Noncurrent Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Convertible Debt Current us-gaap/2024 0 0 monetary I C Convertible Debt, Current The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Revenue Not From Contract With Customer us-gaap/2024 0 0 monetary D C Revenue Not from Contract with Customer Amount of revenue that is not accounted for under Topic 606.
Increase Decrease Fair Value Of Liabilities 0001558370-25-007765 1 0 monetary D D Increase Decrease Fair Value of Liabilities Increase (decrease) fair value of liabilities.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Research And Development Expense Excluding Acquired In Process Cost us-gaap/2024 0 0 monetary D D Research and Development Expense (Excluding Acquired in Process Cost) Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Long Term Debt Current Maturities Other Than Convertible Debt Current 0001558370-25-007765 1 0 monetary I C Long-Term Debt, Current Maturities Other Than Convertible Debt Current Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation and current convertible debt.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Contribution Of Property us-gaap/2024 0 0 monetary D D Contribution of Property Value of property contributed in noncash investing and financing activities.
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction us-gaap/2024 0 0 monetary D D Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Other Liabilities Current us-gaap/2024 0 0 monetary I C Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
Other Nonoperating Expense us-gaap/2024 0 0 monetary D D Other Nonoperating Expense Amount of expense related to nonoperating activities, classified as other.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Assets Current us-gaap/2024 0 0 monetary I D Other Assets, Current Amount of current assets classified as other.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Restricted Cash Noncurrent us-gaap/2024 0 0 monetary I D Restricted Cash, Noncurrent Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Restricted Stock Value Shares Issued Net Of Tax Withholdings us-gaap/2024 0 0 monetary D C Restricted Stock, Value, Shares Issued Net of Tax Withholdings Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Proceeds From Exercise Of Warrants And Stock Options 0001558370-25-007765 1 0 monetary D D Proceeds From Exercise Of Warrants And Stock Options Proceeds from exercise of warrants and stock options.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Increase Decrease In Operating Lease Liability us-gaap/2024 0 0 monetary D D Increase (Decrease) in Operating Lease Liability Amount of increase (decrease) in obligation for operating lease.
Liabilities Fair Value Adjustment us-gaap/2024 0 0 monetary D C Liabilities, Fair Value Adjustment Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.
Restricted Stock Shares Issued Net Of Shares For Tax Withholdings us-gaap/2024 0 0 shares D Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.
Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 0 0 monetary D C Payment, Tax Withholding, Share-Based Payment Arrangement Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Increase Decrease In Operating Lease Right Of Use Asset 0001558370-25-007765 1 0 monetary D C Increase (Decrease) in Operating Lease Right Of Use Asset The amount of increase (decrease) in operating lease right of use asset.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Proceeds From Issuance Of Secured Debt us-gaap/2024 0 0 monetary D D Proceeds from Issuance of Secured Debt The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001558370-25-007765 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001558370-25-007765 2 4 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001558370-25-007765 2 5 BS 0 H Other Assets Current us-gaap/2024 Other receivables 0
0001558370-25-007765 2 6 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001558370-25-007765 2 7 BS 0 H Restricted Cash Noncurrent us-gaap/2024 Restricted cash 0
0001558370-25-007765 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001558370-25-007765 2 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use asset 0
0001558370-25-007765 2 10 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 In-process research and development 0
0001558370-25-007765 2 11 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0001558370-25-007765 2 12 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0001558370-25-007765 2 13 BS 0 H Assets us-gaap/2024 Total assets 0
0001558370-25-007765 2 16 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued liabilities 0
0001558370-25-007765 2 17 BS 0 H Deferred Compensation Liability Current us-gaap/2024 Accrued compensation 0
0001558370-25-007765 2 18 BS 0 H Convertible Debt Current us-gaap/2024 Convertible debt, current 0
0001558370-25-007765 2 19 BS 0 H Long Term Debt Current Maturities Other Than Convertible Debt Current 0001558370-25-007765 Term debt, current 0
0001558370-25-007765 2 20 BS 0 H Operating Lease Liability Current us-gaap/2024 Current portion of operating lease liabilities 0
0001558370-25-007765 2 21 BS 0 H Other Liabilities Current us-gaap/2024 Other current liabilities 0
0001558370-25-007765 2 22 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001558370-25-007765 2 23 BS 0 H Convertible Debt Noncurrent us-gaap/2024 Convertible Loan, non-current 0
0001558370-25-007765 2 24 BS 0 H Secured Long Term Debt us-gaap/2024 Term debt, non-current 0
0001558370-25-007765 2 25 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, net of current portion 0
0001558370-25-007765 2 26 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred tax liability 0
0001558370-25-007765 2 27 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001558370-25-007765 2 28 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 12) 0
0001558370-25-007765 2 30 BS 0 H Common Stock Value us-gaap/2024 Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,193,479 and 36,183,067 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0001558370-25-007765 2 31 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001558370-25-007765 2 32 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001558370-25-007765 2 33 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' deficit 0
0001558370-25-007765 2 34 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' deficit 0
0001558370-25-007765 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001558370-25-007765 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized 0
0001558370-25-007765 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued 0
0001558370-25-007765 3 4 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding 0
0001558370-25-007765 4 1 IS 0 H Revenue Not From Contract With Customer us-gaap/2024 Grant revenue 0
0001558370-25-007765 4 3 IS 0 H Research And Development Expense Excluding Acquired In Process Cost us-gaap/2024 Research and development 0
0001558370-25-007765 4 4 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001558370-25-007765 4 5 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001558370-25-007765 4 6 IS 0 H Operating Income Loss us-gaap/2024 Operating loss 0
0001558370-25-007765 4 8 IS 0 H Other Nonoperating Income us-gaap/2024 Interest income 0
0001558370-25-007765 4 9 IS 0 H Other Nonoperating Expense us-gaap/2024 Interest expense 1
0001558370-25-007765 4 10 IS 0 H Liabilities Fair Value Adjustment us-gaap/2024 Change in fair value of the Convertible Loan 0
0001558370-25-007765 4 12 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Total other income (expense), net 0
0001558370-25-007765 4 13 IS 0 H Net Income Loss us-gaap/2024 Net loss 0
0001558370-25-007765 4 15 IS 0 H Earnings Per Share Basic us-gaap/2024 Net loss per share, basic 0
0001558370-25-007765 4 16 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average shares outstanding, basic 0
0001558370-25-007765 4 17 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net loss per share, diluted 0
0001558370-25-007765 4 18 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average shares outstanding, diluted 0
0001558370-25-007765 5 8 EQ 0 H Stockholders Equity us-gaap/2024 Balances 0
0001558370-25-007765 5 9 EQ 0 H Shares Outstanding us-gaap/2024 Balances (in shares) 0
0001558370-25-007765 5 10 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Exercise of stock options 0
0001558370-25-007765 5 11 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Exercise of stock options (in shares) 0
0001558370-25-007765 5 13 EQ 0 H Restricted Stock Returned Shares Issued Net Of Tax Withholdings 0001558370-25-007765 Withholdings for taxes related to net share settlement of equity awards, shares 1
0001558370-25-007765 5 14 EQ 0 H Restricted Stock Value Shares Issued Net Of Tax Withholdings us-gaap/2024 Issuance of common stock upon release of restricted stock units, net of tax withholdings 0
0001558370-25-007765 5 15 EQ 0 H Restricted Stock Shares Issued Net Of Shares For Tax Withholdings us-gaap/2024 Issuance of common stock upon release of restricted stock units, net of tax withholdings (In shares) 0
0001558370-25-007765 5 16 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0001558370-25-007765 5 17 EQ 0 H Net Income Loss us-gaap/2024 Net loss 0
0001558370-25-007765 5 18 EQ 0 H Stockholders Equity us-gaap/2024 Balances 0
0001558370-25-007765 5 19 EQ 0 H Shares Outstanding us-gaap/2024 Balances (in shares) 0
0001558370-25-007765 6 2 CF 0 H Profit Loss us-gaap/2024 Net loss 0
0001558370-25-007765 6 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization expense 0
0001558370-25-007765 6 5 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0001558370-25-007765 6 6 CF 0 H Increase Decrease Fair Value Of Liabilities 0001558370-25-007765 Change in fair value of the Convertible Loan 0
0001558370-25-007765 6 7 CF 0 H Other Noncash Expense us-gaap/2024 Non-cash interest expense 0
0001558370-25-007765 6 8 CF 0 H Noncash Interest Income 0001558370-25-007765 Non-cash interest income 1
0001558370-25-007765 6 10 CF 0 H Increase Decrease In Operating Lease Right Of Use Asset 0001558370-25-007765 Change in right-of-use asset 1
0001558370-25-007765 6 12 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other assets 1
0001558370-25-007765 6 13 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued liabilities 0
0001558370-25-007765 6 14 CF 0 H Increase Decrease In Deferred Compensation us-gaap/2024 Accrued compensation 0
0001558370-25-007765 6 15 CF 0 H Increase Decrease In Operating Lease Liability us-gaap/2024 Operating lease liability 0
0001558370-25-007765 6 16 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash used in operating activities 0
0001558370-25-007765 6 18 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0001558370-25-007765 6 19 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0001558370-25-007765 6 21 CF 0 H Proceeds From Issuance Of Secured Debt us-gaap/2024 Proceeds from issuance of term debt, net of issuance costs 0
0001558370-25-007765 6 22 CF 0 H Payments Related To Tax Withholding For Share Based Compensation us-gaap/2024 Payments for taxes related to net share settlement of equity awards 1
0001558370-25-007765 6 23 CF 0 H Proceeds From Exercise Of Warrants And Stock Options 0001558370-25-007765 Proceeds from exercise of stock options 0
0001558370-25-007765 6 24 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001558370-25-007765 6 25 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase in cash, cash equivalents and restricted cash 0
0001558370-25-007765 6 26 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash, beginning of period 0
0001558370-25-007765 6 27 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash, end of period 0
0001558370-25-007765 6 29 CF 0 H Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction us-gaap/2024 Unpaid debt issuance costs 0
0001558370-25-007765 6 30 CF 0 H Contribution Of Property us-gaap/2024 Property and equipment included in accounts payable and accrued liabilities 0
0001558370-25-007765 7 2 CF 1 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001558370-25-007765 7 3 CF 1 H Restricted Cash Noncurrent us-gaap/2024 Restricted cash 0
0001558370-25-007765 7 4 CF 1 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.